Second dose range finding trial of grass pollen allergy immunotherapy in US
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- 30 Jun 2016 New trial record
- 27 Jun 2016 According to an Allergy Therapeutics media release, this trial is expected to initiate in 2017.
- 27 Jun 2016 According to an Allergy Therapeutics media release, this trial will employ same trial design as successful European dose-finding trial for birch pollen product (Pollinex Quattro Birch) (see profile 700262266).